Concepedia

Author

Shayan Hobbi

United States Food and Drug Administration

Also Known As

S. Hobbi, Shayan Hobbi

7

Publications

132

Citations

4

H-Index

0

Concepts

All Affiliations

United States Food and Drug AdministrationCenter for Biologics Evaluation and ResearchIBM (United States)Acumen (United States)
SH

About

Shayan Hobbi is an author at United States Food and Drug Administration.

Shayan Hobbi

×

4

Publications

127

Citations

4

H-Index

YearCitations

Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database

Keran Moll, Hui Lee Wong, Kathryn R. Fingar,

Drug Safety

2021

64

Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020

Keran Moll, Bradley Lufkin, Kathryn R. Fingar,

Vaccine

2022

34

Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016–2018

Keran Moll, Hui‐Lee Wong, Kathryn R. Fingar,

Vaccine

2021

19

Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results

Keran Moll, Shayan Hobbi, Cindy Ke Zhou,

PLoS ONE

2022

10

Page 1